Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging.

Chiao YA, Dai Q, Zhang J, Lin J, Lopez EF, Ahuja SS, Chou YM, Lindsey ML, Jin YF.

Circ Cardiovasc Genet. 2011 Aug 1;4(4):455-62. doi: 10.1161/CIRCGENETICS.111.959981. Epub 2011 Jun 17.

2.

Letter by Lee regarding article, "Multi-analyte profiling reveals MMP-9 and MPC-1 as plasma biomarkers of cardiac aging".

Lee R.

Circ Cardiovasc Genet. 2011 Dec;4(6):e30; author reply e31. doi: 10.1161/CIRCGENETICS.111.961110. No abstract available.

3.

Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.

Ma Y, Chiao YA, Zhang J, Manicone AM, Jin YF, Lindsey ML.

Microsc Microanal. 2012 Feb;18(1):81-90. doi: 10.1017/S1431927611012220. Epub 2011 Dec 8.

4.

Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.

Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, Jin YF, Han HC, Manicone AM, Lindsey ML.

Circ Res. 2013 Feb 15;112(4):675-88. doi: 10.1161/CIRCRESAHA.111.300502. Epub 2012 Dec 20.

5.

Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.

Ma Y, Chiao YA, Clark R, Flynn ER, Yabluchanskiy A, Ghasemi O, Zouein F, Lindsey ML, Jin YF.

Cardiovasc Res. 2015 Jun 1;106(3):421-31. doi: 10.1093/cvr/cvv128. Epub 2015 Apr 15.

6.

Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Yabluchanskiy A, Ma Y, Chiao YA, Lopez EF, Voorhees AP, Toba H, Hall ME, Han HC, Lindsey ML, Jin YF.

Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1398-407. doi: 10.1152/ajpheart.00090.2014. Epub 2014 Mar 21.

7.

Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.

Chiao YA, Ramirez TA, Zamilpa R, Okoronkwo SM, Dai Q, Zhang J, Jin YF, Lindsey ML.

Cardiovasc Res. 2012 Dec 1;96(3):444-55. doi: 10.1093/cvr/cvs275. Epub 2012 Aug 22.

8.

Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.

Yan AT, Yan RT, Spinale FG, Afzal R, Gunasinghe HR, Arnold M, Demers C, McKelvie RS, Liu PP.

J Card Fail. 2006 Sep;12(7):514-9.

PMID:
16952784
9.

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.

Sundström J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PW, Vasan RS.

Circulation. 2004 Jun 15;109(23):2850-6. Epub 2004 Jun 1.

10.

Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia.

Slimani H, Zhai Y, Yousif NG, Ao L, Zeng Q, Fullerton DA, Meng X.

Crit Care. 2014 Sep 11;18(5):527. doi: 10.1186/s13054-014-0527-8.

11.

Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis.

Ma Y, Yabluchanskiy A, Hall ME, Lindsey ML.

Atherosclerosis. 2014 Jan;232(1):231-3. doi: 10.1016/j.atherosclerosis.2013.09.013. Epub 2013 Oct 2. No abstract available.

12.

P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9.

DeLeon-Pennell KY, de Castro Brás LE, Iyer RP, Bratton DR, Jin YF, Ripplinger CM, Lindsey ML.

J Mol Cell Cardiol. 2014 Nov;76:218-26. doi: 10.1016/j.yjmcc.2014.09.007. Epub 2014 Sep 18.

13.

Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Toba H, Cannon PL, Yabluchanskiy A, Iyer RP, D'Armiento J, Lindsey ML.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H375-H383. doi: 10.1152/ajpheart.00633.2016. Epub 2016 Dec 23.

PMID:
28011588
15.

Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.

Gonçalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE.

Clin Chim Acta. 2009 May;403(1-2):173-7. doi: 10.1016/j.cca.2009.02.013. Epub 2009 Feb 28.

PMID:
19254704
16.

Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization.

Yabluchanskiy A, Ma Y, DeLeon-Pennell KY, Altara R, Halade GV, Voorhees AP, Nguyen NT, Jin YF, Winniford MD, Hall ME, Han HC, Lindsey ML.

J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):475-83. doi: 10.1093/gerona/glv034. Epub 2015 Apr 15.

17.

Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, Spinale FG.

Cardiovasc Res. 2005 May 1;66(2):410-9. Epub 2004 Dec 13.

PMID:
15820210
18.

Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.

Kitaoka H, Kubo T, Okawa M, Takenaka N, Baba Y, Yamasaki N, Matsumura Y, Furuno T, Doi YL.

J Cardiol. 2011 Nov;58(3):261-5. doi: 10.1016/j.jjcc.2011.07.011. Epub 2011 Sep 3.

19.

Biomarkers of inflammation in major vascular surgery: a prospective randomised trial.

Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA.

Acta Anaesthesiol Scand. 2015 Jul;59(6):773-87. doi: 10.1111/aas.12466. Epub 2015 Jan 28.

PMID:
25626738
20.

Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man?

Weir RA, Murphy CA, Petrie CJ, Martin TN, Clements S, Steedman T, Wagner GS, McMurray JJ, Dargie HJ.

Cytokine. 2010 May;50(2):158-62. doi: 10.1016/j.cyto.2010.02.020. Epub 2010 Mar 17.

PMID:
20299238

Supplemental Content

Support Center